Partial recovery of the endothelial glycocalyx upon rosuvastatin therapy in patients with heterozygous familial hypercholesterolemia

Journal of Lipid Research

Volumn 50, Issue 1, 2009, Pages 148-153

  Meuwese, Marijn C ^a   Mooij, Hans L ^a   Nieuwdorp, Max ^a   van Lith, Bart ^a   Marck, Roos ^a   Vink, Hans ^a,b   Kastelein, John J P ^a   Stroes, Erik S G ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atherosclerosis; Glycosaminoglycans; LDL cholesterol

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; DEXTRAN 40; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; ROSUVASTATIN; TRIACYLGLYCEROL; DEXTRAN; FLUOROBENZENE; HYPOCHOLESTEROLEMIC AGENT; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

ADULT; ARTICLE; BODY MASS; CELL LABELING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIUM CELL; ERYTHROCYTE; FAMILIAL HYPERCHOLESTEROLEMIA; GLYCOCALYX; HETEROZYGOSITY; HUMAN; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DRUG EFFECT; ENDOTHELIUM; GENETICS; HETEROZYGOTE; HYPERCHOLESTEROLEMIA; METABOLISM; MIDDLE AGED; PERMEABILITY;

ADULT; ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DEXTRANS; ENDOTHELIUM; FLUOROBENZENES; GLYCOCALYX; HETEROZYGOTE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PERMEABILITY; PYRIMIDINES; SULFONAMIDES;

EID: 63449141759     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P800025-JLR200     Document Type: Article

References (31)

1. Pries, A. R., T. W. Secomb, and P. Gaehtgens. 2000. The endothelial surface layer. Pflugers Arch. 440: 653-666.
2. Van den Berg, B., H. Vink, and J. A. Spaan. 2003. The endothelial glycocalyx protects against myocardial edema. Circ. Res. 92: 592-594.
3. Van Haaren, P. M., E. Van Bavel, H. Vink, and J. A. Spaan. 2003. Localization of the permeability barrier to solutes in isolated arteries by confocal microscopy. Am. J. Physiol. Heart Circ. Physiol. 285: H2848-H2856.
4. Gorog, P., and G. V. Born. 1983. Uneven distribution of sialic acids on the luminal surface of aortic endothelium. Br. J. Exp. Pathol. 64: 418-424.
5. Henry, C. B., and B. R. Duling. 1999. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am. J. Physiol. 277: H508-H514.
6. Van Haaren, P. M., E. Van Bavel, H. Vink, and J. A. Spaan. 2005. Charge modification of the endothelial surface layer modulates the permeability barrier of isolated rat mesenteric small arteries. Am. J. Physiol. Heart Circ. Physiol. 289: H2503-H2507.
7. Constantinescu, A. A., H. Vink, and J. A. Spaan. 2003. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler. Thromb. Vasc. Biol. 23: 1541-1547.
8. Vink, H., A. A. Constantinescu, and J. A. Spaan. 2000. Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation. 101: 1500-1502.
9. Nieuwdorp, M., T. W. van Haeften, M. C. Gouverneur, H. L. Mooij, M. H. van Lieshout, M. Levi, J. C. Meijers, F. Holleman, J. B. Hoekstra, H. Vink, et al. 2006. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes. 55: 480-486.
10. Nieuwdorp, M., H. L. Mooij, J. Kroon, B. Atasever, J. A. Spaan, C. Ince, F. Holleman, M. Diamant, R. J. Heine, J. B. Hoekstra, et al. 2006. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes. 55: 1127-1132.
11. Deckert, T., B. Feldt-Rasmussen, K. Borch-Johnsen, T. Jensen, and A. Kofoed-Enevoldsen. 1989. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia. 32: 219-226.
12. Czarnowska, E., and E. Karwatowska-Prokopczuk. 1995. Ultra-structural demonstration of endothelial glycocalyx disruption in the reperfused rat heart. Involvement of oxygen free radicals. Basic Res. Cardiol. 90: 357-364.
13. Rubio-Gayosso, I., S. H. Platts, and B. R. Duling. 2006. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 290: H2247-H2256.
14. Henry, C. B., and B. R. Duling. 2000. TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am. J. Physiol. Heart Circ. Physiol. 279: H2815-H2823.
15. Vink, H., and B. R. Duling. 1996. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ. Res. 79: 581-589.
16. Van Kreel, B. K., E. van Beek, M. E. Spaanderman, and L. L. Peeters. 1998. A new method for plasma volume measurements with unlabeled Dextran-70 instead of 125I labeled albumin as an indicator. Clin. Chim. Acta. 275: 71-80.
17. Orth, V. H., M. Rehm, M. Thiel, U. Kreimeier, M. Haller, H. Brechtelsbauer, and U. Finsterer. 1998. First clinical implications of perioperative red cell volume measurement with a nonradio-active marker (sodium fluorescein). Anesth. Analg. 87: 1234-1238.
18. Nieuwdorp, M., M. C. Meuwese, H.L. Mooij, C. Ince, L.N. Broekhuizen, J. J. Kastelein, E. S. Stroes, and H. Vink. 2008. Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability. J. Appl. Physiol. 104: 845-852.
19. Han, Y., S. Weinbaum, J. A. E. Spaan, and H. Vink. 2006. Large deformation analysis of the elastic recoil of fiber layers in a Brinkman medium with application to the endothelial glycocalyx. J. Fluid Mech. 554: 217-235.
20. Frost, G. I., and R. Stern. 1997. A microtiter-based assay for hyaluronidase activity not requiring specialized reagents. Anal. Biochem. 251: 263-269.
21. Nouroooz-Zadeh, J., C. C. T. Smith, and D. J. Betteridge. 2001. Measures of oxidative stress in heterozygous familial hypercholesterolaemia. Circulation. 156: 435-441.
22. Reilly, M. P., D. Pratico, N. Delanty, G. DiMinno, E. Tremoli, D. Rader, S. Kapoor, J. Rokach, J. Lawson, and G. A. FitzGerald. 1998. Increased formation of distinct F2 isoprostanes in hypercholesterolemia. Circulation. 98: 2822-2828.
23. Van de Berg, B. M., J. A. E. Spaan, T. M. Rolf, and H. Vink. 2005. Atherogenic region and diet diminish glycocalyx dimension and increase intima-to-media ratios at murine carotid artery bifurcation. Am. J. Physiol. Heart Circ. Physiol. 290: H915-H920.
24. Gorog, P., and G. V. Born. 1982. Increased uptake of circulating low-density lipoproteins and fibrinogen by arterial walls after removal of sialic acids from their endothelial surface. Br. J. Exp. Pathol. 63: 447-451.
25. Dell'Omo, G., S. Bandinelli, G. Penno, R. Pedrinelli, and M. Mariani. 2000. Simvastatin, capillary permeability, and acetylcholine-mediated vasomotion in atherosclerotic, hypercholesterolemic men. Clin. Pharmacol. Ther. 68: 427-434.
26. Ueland, T., M. N. Vissers, A. Wiegman, J. Rodenburg, B. Hutten, L. Gullestad, L. Ose, N. Rifai, P. M. Ridker, J. J. Kastelein, et al. 2006. Increased inflammatory markers in children with familial hypercholesterolaemia. Eur. J. Clin. Invest. 36: 147-152.
27. Dupuis, J., J. C. Tardif, P. Cernacek, and P. Theroux. 1999. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation. 99: 3227-3233.
28. Stroes, E. S. G., H. A. Koomans, T. W. A. de Bruin, and T. J. Rabelink. 1995. Vascular function in the forearm of hypercholesterolaemic patiens off and on lipid-lowering medication. Lancet. 346: 467-471.
29. Ihnat, M. A., J. E. Thorpe, C. D. Kamat, C. Szabo, D. E. Green, L. A. Warnke, Z. Lacza, A. Cselenyak, K. Ross, S. Shakir, et al. 2007. Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. Diabetologia. 50: 1523-1531.
30. Van Thienen, J. V., J. O. Fledderus, R. J. Dekker, J. Rohlena, G. A. van Ijzendoorn, N. A. Kootstra, H. Pannekoek, and A. J. Horrevoets. 2006. Shear stress sustains atheroprotective endothelial KLF2 expression more potently than statins through mRNA stabilization. Cardiovasc. Res. 72: 231-240.
31. Dekker, R. J., R. A. Boon, M. G. Rondaij, A. Kragt, O. L. Volger, Y. W. Elderkamp, J. C. Meijers, J. Voorberg, H. Pannekoek, and A. J. Horrevoets. 2006. KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood. 107: 4354-4363.